219 related articles for article (PubMed ID: 25209395)
1. Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Goto H; Ito S; Adachi M; Yoshida H; Yuki H; Inoue T
Radiat Oncol; 2014 Sep; 9():201. PubMed ID: 25209395
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
[TBL] [Abstract][Full Text] [Related]
3. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
4. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
Raleigh DR; Tomlin B; Buono BD; Roddy E; Sear K; Byer L; Felton E; Banerjee A; Torkildson J; Samuel D; Horn B; Braunstein SE; Haas-Kogan DA; Mueller S
J Neurooncol; 2017 Jan; 131(2):359-368. PubMed ID: 27778212
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
Roehrig A; Indelicato DJ; Paulino AC; Ermoian R; Hartsell W; Perentesis J; Hill-Kayser C; Lee JY; Laack NN; Mangona V; MacEwan I; Eaton BR; Gallotto S; Bajaj BVM; Aridgides PD; Yock TI
J Neurooncol; 2023 Apr; 162(2):353-362. PubMed ID: 36951945
[TBL] [Abstract][Full Text] [Related]
6. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system tumors in patients under three years of age: treatment results of a single institute.
Varan A; Akalan N; Söylemezoğlu F; Zorlu F; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
Pediatr Neurosurg; 2006; 42(2):89-94. PubMed ID: 16465077
[TBL] [Abstract][Full Text] [Related]
8. Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors.
Campen CJ; Dearlove J; Partap S; Murphy P; Gibbs IC; Dahl GV; Fisher PG
J Neurooncol; 2012 Nov; 110(2):287-91. PubMed ID: 22941430
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
[TBL] [Abstract][Full Text] [Related]
10. Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study.
Robertson PL; Jakacki R; Hukin J; Siffert J; Allen JC
J Neurooncol; 2014 May; 118(1):93-100. PubMed ID: 24700239
[TBL] [Abstract][Full Text] [Related]
11. High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702).
Nazemi KJ; Shen V; Finlay JL; Boyett J; Kocak M; Lafond D; Gardner SL; Packer RJ; Nicholson HS
Pediatr Blood Cancer; 2016 Sep; 63(9):1563-70. PubMed ID: 27203542
[TBL] [Abstract][Full Text] [Related]
12. Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors.
Mizumoto M; Oshiro Y; Pan H; Wang F; Kaste SC; Gajjar A; Chemaitilly W; Merchant TE
Pediatr Blood Cancer; 2020 Oct; 67(10):e28617. PubMed ID: 32715632
[TBL] [Abstract][Full Text] [Related]
13. Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Souweidane M; Lu HM; Morris D; Panigrahy A; Onar-Thomas A; Fouladi M; Gajjar A; Dhall G
J Clin Oncol; 2019 Dec; 37(34):3283-3290. PubMed ID: 31545689
[TBL] [Abstract][Full Text] [Related]
14. The impact on outcomes by using thiotepa in tandem transplant for pediatric high-risk embryonal brain tumors.
Yen HJ; Yu TY; Lee CY; Hung GY; Chiou TJ; Chen HH; Lee YY; Liang ML; Chen YW
J Chin Med Assoc; 2019 Feb; 82(2):148-154. PubMed ID: 30839507
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962
[TBL] [Abstract][Full Text] [Related]
16. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
[TBL] [Abstract][Full Text] [Related]
17. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
[TBL] [Abstract][Full Text] [Related]
18. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
[TBL] [Abstract][Full Text] [Related]
19. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors.
Murphy ES; Merchant TE; Wu S; Xiong X; Lukose R; Wright KD; Qaddoumi I; Armstrong GT; Broniscer A; Gajjar A
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e655-60. PubMed ID: 22768993
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD
J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
